Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 466

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 466
---
 shares of common stock held indirectly by the Anishka Irrevocable 2016 Trust dated October 19, 2016 (the “Anishka Irrevocable Trust”), and (iii) 458,575 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025. Dr. Desai disclaims beneficial ownership of the securities held in the Anishka Irrevocable Trust, except to the extent of any pecuniary interest therein.                                                             |

| (10) | Consists of (i) 349,761 shares of common stock issuable upon the exercise of options within 60 days of January                                                                                  
 30, 2025 (ii); 7,500 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025 and (iii) 3,000 shares of common stock held indirectly by Dr. Itri’s spouse. |

| (11) | Consists of (i) 19,694 shares of common stock held directly by Dr. Castelein, (ii) 499,998 shares of                                                                                                                             
 common stock held indirectly by KVP Capital, LP (“KVP Capital”), and (iii) 71,895 shares of common stock issuable upon the exercise of options within 60 days of January 30, 2025. Dr. Castelein is the Managing Director of KVP 
 Capital and Dr. Castelein disclaims beneficial ownership of the shares held by KVP Capital, except to the extent of his pecuniary interest therein.                                                                              |

| (12) | Consists of (i) the securities listed in footnote (1) above and (ii) 64,377 shares of common stock 
 issuable upon the exercise of options within 60 days of January 30, 2025.                          |

| (13) | Consists of (i) 1,130 shares of common stock held directly by Dr. Dalal; (ii) the securities listed                                      
 in footnote (2) above, and (iii) 71,895 shares of common stock issuable upon the exercise of options within 60 days of January 30, 2025. |

| (14) | Consists of 63,314 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (15) | Consists